Idiopathic pulmonary fibrosis Clinical Trials

Recruiting idiopathic pulmonary fibrosis studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat idiopathic pulmonary fibrosis. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting idiopathic pulmonary fibrosis studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting idiopathic pulmonary fibrosis trials

Within

Dose-Escalation Study of Artesunate Patients With IPF

for Idiopathic Pulmonary Fibrosis

1 site in Stanford

Sponsor: Joseph C. Wu

Sex: All·Age: 40+

Code: NCT05988463·Phase 1

Apply to this trial

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

9 sites incl. Birmingham

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 40 - 85

Code: NCT07674745·Phase 2

Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

Sponsor: InSilico Medicine Hong Kong Limited

Sex: All·Age: 40+

Code: NCT07687459·Phase 3

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

1 site in Worcester

Sponsor: University of Massachusetts, Worcester

Sex: All·Age: 40+

Code: NCT07520110·Phase 3

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All·Age: 40+

Code: NCT07516951·Phase 2

Apply to this trial

A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: InnovStone Therapeutics Limited

Sex: All·Age: 40+

Code: NCT07600021·Phase 2

Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Mannkind Corporation

Sex: All·Age: 40 - 80

Code: NCT07679893·Phase 2

Apply to this trial

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

for Idiopathic Pulmonary Fibrosis

5 sites incl. Loxahatchee Groves

Sponsor: Trevi Therapeutics

Sex: All·Age: 40+

Code: NCT07671911·Phase 3

Apply to this trial

Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects

for Solid Tumor

Sponsor: SCBIO Inc.

Sex: Male·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07682337·Phase 1

OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: University of Modena and Reggio Emilia

Sex: All·Age: 18 - 90

Code: NCT07404423

A Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 (Taladegib) in Healthy Participants

for Idiopathic Pulmonary Fibrosis

Sponsor: Endeavor Biomedicines, Inc.

Sex: All·Age: 26 - 65·Accepts healthy volunteers

Code: NCT07454291·Phase 1

Apply to this trial

Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

Sponsor: University Hospital Southampton NHS Foundation Trust

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT06488638

Apply to this trial

Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Argyrios Tzouvelekis

Sex: All·Age: 18+

Code: NCT07299695·Phase 3

Apply to this trial

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

3 sites incl. Dothan

Sponsor: AbbVie

Sex: All·Age: 40+

Code: NCT07230288·Phase 2

Apply to this trial

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Contineum Therapeutics

Sex: All·Age: 40+

Code: NCT07284459·Phase 2

Apply to this trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males

for Idiopathic Pulmonary Fibrosis

Sponsor: siRNAgen Therapeutics Inc.

Sex: Male·Age: 19 - 60·Accepts healthy volunteers

Code: NCT07407543·Phase 1

Apply to this trial

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

for Idiopathic Pulmonary Fibrosis

15 sites incl. Birmingham

Sponsor: Boehringer Ingelheim

Sex: All·Age: 40+

Code: NCT07036523·Phase 2

Apply to this trial

Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

1 site in Los Angeles

Sponsor: Cedars-Sinai Medical Center

Sex: All·Age: 50+

Code: NCT06567717·Phase 2

Apply to this trial

NAL ER IPF Respiratory Function and Safety Study

for Idiopathic Pulmonary Fibrosis

1 site in Rochester

Sponsor: Trevi Therapeutics

Sex: All·Age: 18+

Code: NCT07036029·Phase 1

Apply to this trial

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

for Pulmonary Fibrosis, Interstitial Lung Disease

Sponsor: Vejle Hospital

Sex: All·Age: 18+

Code: NCT06714123·Phase 2

Apply to this trial

Daoyin Technique for Improving Exercise Endurance in IPF

for Idiopathic Pulmonary Fibrosis

Sponsor: Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

Sex: All·Age: 40 - 85

Code: NCT07019714

Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)

for Idiopathic Pulmonary Fibrosis

Sponsor: University of Milan

Sex: All·Age: 18+

Code: NCT07312305

Apply to this trial

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

for Interstitial Lung Disease

1 site in Research Triangle Park

Sponsor: National Institute of Environmental Health Sciences (NIEHS)

Sex: All·Age: 18 - 100

Code: NCT06325696·Phase 2

Apply to this trial

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

26 sites incl. Birmingham

Sponsor: Mediar Therapeutics

Sex: All·Age: 40+

Code: NCT06967805·Phase 2

Apply to this trial

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

1 site in Charlottesville

Sponsor: University of Virginia

Sex: All·Age: 18+

Code: NCT06853145·EARLY_Phase 1

Apply to this trial

SB17170 Phase 2 Trial in IPF Patients

for IPF

Sponsor: SPARK Biopharma

Sex: All·Age: 40+

Code: NCT06747923·Phase 2

Apply to this trial

Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Hacettepe University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06668051

Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis

for Familial Pulmonary Fibrosis

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06521125

Skeletal Muscle Function in Interstitial Lung Disease

for Interstitial Lung Disease

Sponsor: University of British Columbia

Sex: All·Age: 40 - 80·Accepts healthy volunteers

Code: NCT03800017

Apply to this trial

Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Chu Hongling

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT06629623

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

1 site in Charlottesville

Sponsor: University of Virginia

Sex: All·Age: 40 - 101

Code: NCT06323876

Apply to this trial

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

for Idiopathic Pulmonary Fibrosis

8 sites incl. Birmingham

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06238622·Phase 3

Apply to this trial

Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

Sponsor: Wuhan Optics Valley Vcanbiopharma Co., Ltd.

Sex: All·Age: 40 - 75

Code: NCT06230822·Phase 1

Apply to this trial

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

19 sites incl. La Mesa

Sponsor: Cumberland Pharmaceuticals

Sex: All·Age: 40+

Code: NCT05571059·Phase 2

Apply to this trial

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

for Idiopathic Pulmonary Fibrosis

Sponsor: Shanghai Synvida Biotechnology Co.,Ltd.

Sex: All·Age: 18 - 45

Code: NCT06267183·EARLY_Phase 1

Apply to this trial

Validation of the C-mo System - Cough Monitoring

for Cough

Sponsor: Cough Monitoring Medical Solutions

Sex: All·Age: 2+

Code: NCT05989698

Apply to this trial

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

Sponsor: Guangzhou JOYO Pharma Co., Ltd

Sex: All·Age: 40 - 80

Code: NCT06125327·Phase 2, Phase 3

Apply to this trial

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Assiut University

Sex: All·Age: 18 - 80

Code: NCT05842681

Apply to this trial

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

for Pulmonary Fibrosis

Sponsor: Erasme University Hospital

Sex: All·Age: 18+

Code: NCT06189820·Phase 2

Apply to this trial

End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation

for Idiopathic Pulmonary Fibrosis

Sponsor: University of Modena and Reggio Emilia

Sex: All·Age: 18 - 90

Code: NCT05098717

Apply to this trial

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

for Idiopathic Pulmonary Fibrosis

86 sites incl. Birmingham

Sponsor: United Therapeutics

Sex: All·Age: 40+

Code: NCT04905693·Phase 3

Pulmonary Fibrosis Foundation Community Registry

for Pulmonary Fibrosis

1 site in Chicago

Sponsor: Pulmonary Fibrosis Foundation

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05382572

Apply to this trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

for Idiopathic Pulmonary Fibrosis

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All·Age: All ages

Code: NCT05016817·Phase 1

Apply to this trial

Effects of Pulmonary Diseases and Their Treatment on Cardiac Function

for COPD

Sponsor: Ayham Daher

Sex: All·Age: 18 - 99

Code: NCT05042219

Apply to this trial

Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland

for Connective Tissue Diseases

Sponsor: Royal College of Surgeons, Ireland

Sex: All·Age: 18 - 85

Code: NCT06702228

Apply to this trial

Interstitial Lung Disease Research Unit Biobank

for Interstitial Lung Disease

1 site in Kansas City

Sponsor: University of Kansas Medical Center

Sex: All·Age: 18+

Code: NCT05392881

Apply to this trial

Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

for Idiopathic Pulmonary Fibrosis

Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust

Sex: All·Age: 40+

Code: NCT04965298·Phase 3

Apply to this trial

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

1 site in Birmingham

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 40 - 85

Code: NCT04362644·Phase 1

Apply to this trial

Cohort of IPF Patients Experiencing an Exacerbation

for Idiopathic Pulmonary Fibrosis

Sponsor: University Hospital, Gentofte, Copenhagen

Sex: All·Age: 18+

Code: NCT04442711

Apply to this trial

University of Virginia Natural History Study

for Interstitial Lung Disease

1 site in Charlottesville

Sponsor: University of Virginia

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04896138

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

for Idiopathic Pulmonary Fibrosis

2 sites in Pittsburgh

Sponsor: Paul Szabolcs

Sex: All·Age: 18 - 60

Code: NCT03500731·Phase 1, Phase 2

Apply to this trial

Controls for Respiratory Diseases

for Chronic Obstructive Pulmonary Disease

Sponsor: Seoul National University Hospital

Sex: All·Age: 19 - 90·Accepts healthy volunteers

Code: NCT03120481

Apply to this trial

Korean Idiopathic Pulmonary Fibrosis Registry

for Idiopathic Pulmonary Fibrosis

Sponsor: Seoul National University Hospital

Sex: All·Age: 30 - 100

Code: NCT04160715

Apply to this trial

Mechanisms of Familial Pulmonary Fibrosis

for Familial Pulmonary Fibrosis

1 site in Nashville

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 40 - 75

Code: NCT03437486

Apply to this trial

The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study

for Idiopathic Pulmonary Fibrosis

Sponsor: University of Edinburgh

Sex: All·Age: 18 - 99

Code: NCT04016181

Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

1 site in Pittsburgh

Sponsor: University of Pittsburgh

Sex: All·Age: 18+

Code: NCT00373841

Apply to this trial

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

for Interstitial Lung Diseases

1 site in Chicago

Sponsor: University of Chicago

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT00470327

Apply to this trial

Idiopathic pulmonary fibrosis clinical trials — common questions

Are idiopathic pulmonary fibrosis clinical trials free to join?

Yes. Participating in a idiopathic pulmonary fibrosis clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a idiopathic pulmonary fibrosis clinical trial?

Each idiopathic pulmonary fibrosis study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a idiopathic pulmonary fibrosis trial near me?

Use the location controls above. We'll show recruiting idiopathic pulmonary fibrosis trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many idiopathic pulmonary fibrosis trials are recruiting right now?

We're currently tracking roughly 24 recruiting idiopathic pulmonary fibrosis trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Idiopathic pulmonary fibrosis trials by city

Birmingham, AL Chicago, IL Los Angeles, CA Stanford, CA Worcester, MA

Related specialties

Pulmonology Lung disease